The Board of Directors of Rocky Mountain Ginseng, Inc. (Pink Sheets:RMGG) wish to report that the Company’s Annual Shareholders Meeting was adjourned at the May 3rd meeting due to the lack of a quorum.

Brian Hodge, president of RMGG, announced at the meeting that the Annual Shareholders Meeting will recommence on Friday, June 8, 2001, at 10:00 a.m. and will be held at the Century Plaza Hotel in Vancouver, B.C. Canada.

The Directors of RMGG urge all shareholders who did not vote to do so prior to June 8th.


Rocky Mountain Ginseng, Inc.’s head office is located in British Columbia, Canada. The Company exports American ginseng to China as well as manufactures and processes America ginseng products in China. Rocky Mountain Ginseng, Inc. holds exclusive world processing and distribution rights to several innovative value added ginseng products developed in North America.

Rocky Mountain Ginseng, Inc. purchased Fuzhou Fujian Drug Company located in China in February 1999. This acquisition included all necessary drug and hygiene licenses allowing the Company to import, export, manufacture and distribute ginseng products in all provinces of China. The Company has completed the construction of its new office and manufacturing facility in the city of Fuzhou and is currently producing traditional ginseng products for the Chinese Market. The Chinese factory employs 42 people in processing, sales, accounting and management. Rocky Mountain (Fuzhou) Drug Co. Ltd. is the first wholly owned Canadian Company in the Fujian province.

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Expression of future goals and similar expressions reflecting something other than historical fact involve risks and uncertainties. The actual results the company achieves may differ materially from any forward-looking statements due to such risks and uncertainties.